Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

dapoxetine

Known as: N,N-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)benzenemethanamine, Dapoxetinum, Dapoxetina 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVE To assess both the acceptance and the discontinuation rates from dapoxetine, the first oral pharmacological agent… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
INTRODUCTION Dapoxetine has been evaluated for the on-demand treatment of premature ejaculation (PE) in five phase 3 studies in… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
INTRODUCTION Dapoxetine is a short-acting selective serotonin reuptake inhibitor that was recently approved for the on-demand… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
INTRODUCTION Premature ejaculation (PE) is classified as an acquired or lifelong condition but data on baseline characteristics… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Dapoxetine is being developed for the on-demand treatment of premature ejaculation (PE). Previous clinical trials have… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
To evaluate the reliability and validity of the Premature Ejaculation Profile (PEP), a self‐reported outcome instrument for… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
To evaluate the overall treatment benefit of dapoxetine for premature ejaculation (PE), with specific emphasis on improvements in… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Potential pharmacokinetic interactions between dapoxetine, a serotonin transporter inhibitor developed for the treatment of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2006